Pain Management
Migraines
More in Migraines
Triptans are efficacious and underused, researchers say
Investigational Lu AG09222 met primary end point in proof-of-concept trial
But not everyone can reliably identify prodrome events, notes expert
At 48 weeks, atogepant showed consistent safety profile and efficacy
Headache episodes during long space travel more common than previously thought
Acute migraine drugs raised ischemic event odds for people with underlying risk factors
Anxiety, depression, stress as headache predictors were superseded by sleep changes
Physical isolation and lack of specialty care may play a role
Imaging links inflammation to migraine and tension headaches
Researchers compared headache diary data before and after vaccination or infection
Gepant reduced number of monthly migraine days
Findings may influence treatment approaches for some patients
Awareness of sex differences in symptoms, triggers may increase diagnosis and treatment in women
Patients had significant changes in perivascular spaces
